ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriatic Arthritis Therapeutics Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-7G14359
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Psoriatic Arthritis Therapeutics Drug Market Research Report 2023
BUY CHAPTERS

Global Psoriatic Arthritis Therapeutics Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-7G14359
Report
December 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Janssen Biotech
Novartis
Amgen Inc
Celgene Corporation
Pfizer Inc
Eli Lilly
UCB
Biogen
Bristol–Myers Squibb

Psoriatic Arthritis Therapeutics Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriatic Arthritis Therapeutics Drug Market

Psoriatic Arthritis Therapeutics Drug Market

Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
The global Psoriatic Arthritis Therapeutics Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Psoriatic Arthritis Therapeutics Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Psoriatic Arthritis Therapeutics Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Psoriatic Arthritis Therapeutics Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psoriatic Arthritis Therapeutics Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Psoriatic Arthritis Therapeutics Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Psoriatic Arthritis Therapeutics Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Psoriatic Arthritis Therapeutics Drug Market Report

Report Metric Details
Report Name Psoriatic Arthritis Therapeutics Drug Market
CAGR 5%
Segment by Type
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB, Biogen, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Psoriatic Arthritis Therapeutics Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Psoriatic Arthritis Therapeutics Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psoriatic Arthritis Therapeutics Drug sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The main players in the Psoriatic Arthritis Therapeutics Drug Market are Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB, Biogen, Bristol-Myers Squibb

What are the Application segmentation covered in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The Applications covered in the Psoriatic Arthritis Therapeutics Drug Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Psoriatic Arthritis Therapeutics Drug Market report?

Ans: The Types covered in the Psoriatic Arthritis Therapeutics Drug Market report are NF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, Others

Recommended Reports

Inflammatory Disease Drugs

Autoimmune & Arthritis Therapy

Specialty Disease Treatment

1 Study Coverage
1.1 Psoriatic Arthritis Therapeutics Drug Product Introduction
1.2 Market by Type
1.2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 NF Inhibitors
1.2.3 Interleukin Inhibitors
1.2.4 PDE4 Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region
2.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2024)
2.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2025-2030)
2.2.4 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2019-2030)
2.3 Global Psoriatic Arthritis Therapeutics Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Psoriatic Arthritis Therapeutics Drug Sales by Region
2.4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2024)
2.4.3 Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2025-2030)
2.4.4 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
3.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Psoriatic Arthritis Therapeutics Drug in 2023
3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
3.2.1 Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Drug Revenue in 2023
3.3 Global Key Players of Psoriatic Arthritis Therapeutics Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Psoriatic Arthritis Therapeutics Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Offered and Application
3.8 Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Historical Sales by Type (2019-2024)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
4.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type
4.2.1 Global Psoriatic Arthritis Therapeutics Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
4.3 Global Psoriatic Arthritis Therapeutics Drug Price by Type
4.3.1 Global Psoriatic Arthritis Therapeutics Drug Price by Type (2019-2024)
4.3.2 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application
5.1.1 Global Psoriatic Arthritis Therapeutics Drug Historical Sales by Application (2019-2024)
5.1.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
5.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application
5.2.1 Global Psoriatic Arthritis Therapeutics Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Psoriatic Arthritis Therapeutics Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
5.3 Global Psoriatic Arthritis Therapeutics Drug Price by Application
5.3.1 Global Psoriatic Arthritis Therapeutics Drug Price by Application (2019-2024)
5.3.2 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Psoriatic Arthritis Therapeutics Drug Market Size by Type
6.1.1 US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
6.1.2 US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
6.2 US & Canada Psoriatic Arthritis Therapeutics Drug Market Size by Application
6.2.1 US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
6.2.2 US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
6.3 US & Canada Psoriatic Arthritis Therapeutics Drug Market Size by Country
6.3.1 US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
6.3.3 US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Type
7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
7.2 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Application
7.2.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
7.2.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
7.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size by Country
7.3.1 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
7.3.3 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Psoriatic Arthritis Therapeutics Drug Market Size
8.1.1 China Psoriatic Arthritis Therapeutics Drug Sales (2019-2030)
8.1.2 China Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030)
8.2 China Psoriatic Arthritis Therapeutics Drug Market Size by Application
8.2.1 China Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
8.2.2 China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Psoriatic Arthritis Therapeutics Drug Market Size by Type
9.1.1 Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
9.1.2 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
9.2 Asia Psoriatic Arthritis Therapeutics Drug Market Size by Application
9.2.1 Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
9.2.2 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
9.3 Asia Psoriatic Arthritis Therapeutics Drug Sales by Region
9.3.1 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2030)
9.3.3 Asia Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Janssen Biotech
11.2.1 Janssen Biotech Company Information
11.2.2 Janssen Biotech Overview
11.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Biotech Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Overview
11.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amgen Recent Developments
11.5 CELGENE CORPORATION
11.5.1 CELGENE CORPORATION Company Information
11.5.2 CELGENE CORPORATION Overview
11.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CELGENE CORPORATION Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Eli Lilly
11.7.1 Eli Lilly Company Information
11.7.2 Eli Lilly Overview
11.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Eli Lilly Recent Developments
11.8 UCB
11.8.1 UCB Company Information
11.8.2 UCB Overview
11.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 UCB Recent Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Overview
11.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biogen Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Psoriatic Arthritis Therapeutics Drug Industry Chain Analysis
12.2 Psoriatic Arthritis Therapeutics Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Psoriatic Arthritis Therapeutics Drug Production Mode & Process
12.4 Psoriatic Arthritis Therapeutics Drug Sales and Marketing
12.4.1 Psoriatic Arthritis Therapeutics Drug Sales Channels
12.4.2 Psoriatic Arthritis Therapeutics Drug Distributors
12.5 Psoriatic Arthritis Therapeutics Drug Customers
13 Market Dynamics
13.1 Psoriatic Arthritis Therapeutics Drug Industry Trends
13.2 Psoriatic Arthritis Therapeutics Drug Market Drivers
13.3 Psoriatic Arthritis Therapeutics Drug Market Challenges
13.4 Psoriatic Arthritis Therapeutics Drug Market Restraints
14 Key Findings in The Global Psoriatic Arthritis Therapeutics Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
AbbVie
Janssen Biotech
Novartis
Amgen Inc
Celgene Corporation
Pfizer Inc
Eli Lilly
UCB
Biogen
Bristol–Myers Squibb
List of Tables
    Table 1. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of NF Inhibitors
    Table 3. Major Manufacturers of Interleukin Inhibitors
    Table 4. Major Manufacturers of PDE4 Inhibitors
    Table 5. Major Manufacturers of Others
    Table 6. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Psoriatic Arthritis Therapeutics Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2019-2024)
    Table 11. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2025-2030)
    Table 12. Global Psoriatic Arthritis Therapeutics Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2024) & (K Units)
    Table 14. Global Psoriatic Arthritis Therapeutics Drug Sales by Region (2025-2030) & (K Units)
    Table 15. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2019-2024)
    Table 16. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2025-2030)
    Table 17. Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Manufacturers (2019-2024)
    Table 19. Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Psoriatic Arthritis Therapeutics Drug, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Psoriatic Arthritis Therapeutics Drug Price by Manufacturers 2019-2024 (USD/Unit)
    Table 23. Global Psoriatic Arthritis Therapeutics Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Psoriatic Arthritis Therapeutics Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Therapeutics Drug as of 2023)
    Table 25. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Product Offered and Application
    Table 27. Global Key Manufacturers of Psoriatic Arthritis Therapeutics Drug, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 30. Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 31. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2019-2024)
    Table 32. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2025-2030)
    Table 33. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2019-2024)
    Table 36. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2025-2030)
    Table 37. Psoriatic Arthritis Therapeutics Drug Price by Type (2019-2024) & (USD/Unit)
    Table 38. Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 39. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 40. Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 41. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2019-2024)
    Table 42. Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2025-2030)
    Table 43. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2019-2024)
    Table 46. Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Application (2025-2030)
    Table 47. Psoriatic Arthritis Therapeutics Drug Price by Application (2019-2024) & (USD/Unit)
    Table 48. Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 49. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 62. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 63. Europe Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 64. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 67. Europe Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 68. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 74. Europe Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 75. China Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 76. China Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 77. China Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 80. China Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 81. China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 84. Asia Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 85. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 88. Asia Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 89. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Psoriatic Arthritis Therapeutics Drug Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Psoriatic Arthritis Therapeutics Drug Sales by Region (2019-2024) & (K Units)
    Table 95. Asia Psoriatic Arthritis Therapeutics Drug Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country (2025-2030) & (K Units)
    Table 109. AbbVie Company Information
    Table 110. AbbVie Description and Major Businesses
    Table 111. AbbVie Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 112. AbbVie Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. AbbVie Recent Developments
    Table 114. Janssen Biotech Company Information
    Table 115. Janssen Biotech Description and Major Businesses
    Table 116. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 117. Janssen Biotech Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Janssen Biotech Recent Developments
    Table 119. Novartis Company Information
    Table 120. Novartis Description and Major Businesses
    Table 121. Novartis Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 122. Novartis Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Novartis Recent Developments
    Table 124. Amgen Company Information
    Table 125. Amgen Description and Major Businesses
    Table 126. Amgen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 127. Amgen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Amgen Recent Developments
    Table 129. CELGENE CORPORATION Company Information
    Table 130. CELGENE CORPORATION Description and Major Businesses
    Table 131. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 132. CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. CELGENE CORPORATION Recent Developments
    Table 134. Pfizer Company Information
    Table 135. Pfizer Description and Major Businesses
    Table 136. Pfizer Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 137. Pfizer Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Pfizer Recent Developments
    Table 139. Eli Lilly Company Information
    Table 140. Eli Lilly Description and Major Businesses
    Table 141. Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 142. Eli Lilly Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Eli Lilly Recent Developments
    Table 144. UCB Company Information
    Table 145. UCB Description and Major Businesses
    Table 146. UCB Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 147. UCB Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. UCB Recent Developments
    Table 149. Biogen Company Information
    Table 150. Biogen Description and Major Businesses
    Table 151. Biogen Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 152. Biogen Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Biogen Recent Developments
    Table 154. Bristol-Myers Squibb Company Information
    Table 155. Bristol-Myers Squibb Description and Major Businesses
    Table 156. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 157. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Bristol-Myers Squibb Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Psoriatic Arthritis Therapeutics Drug Distributors List
    Table 162. Psoriatic Arthritis Therapeutics Drug Customers List
    Table 163. Psoriatic Arthritis Therapeutics Drug Market Trends
    Table 164. Psoriatic Arthritis Therapeutics Drug Market Drivers
    Table 165. Psoriatic Arthritis Therapeutics Drug Market Challenges
    Table 166. Psoriatic Arthritis Therapeutics Drug Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Psoriatic Arthritis Therapeutics Drug Product Picture
    Figure 2. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Psoriatic Arthritis Therapeutics Drug Market Share by Type in 2023 & 2030
    Figure 4. NF Inhibitors Product Picture
    Figure 5. Interleukin Inhibitors Product Picture
    Figure 6. PDE4 Inhibitors Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Psoriatic Arthritis Therapeutics Drug Market Share by Application in 2023 & 2030
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Psoriatic Arthritis Therapeutics Drug Report Years Considered
    Figure 14. Global Psoriatic Arthritis Therapeutics Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Psoriatic Arthritis Therapeutics Drug Revenue 2019-2030 (US$ Million)
    Figure 16. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Region (2019-2030)
    Figure 18. Global Psoriatic Arthritis Therapeutics Drug Sales 2019-2030 ((K Units)
    Figure 19. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Psoriatic Arthritis Therapeutics Drug Sales YoY (2019-2030) & (K Units)
    Figure 21. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Psoriatic Arthritis Therapeutics Drug Sales YoY (2019-2030) & (K Units)
    Figure 23. Europe Psoriatic Arthritis Therapeutics Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Psoriatic Arthritis Therapeutics Drug Sales YoY (2019-2030) & (K Units)
    Figure 25. China Psoriatic Arthritis Therapeutics Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Psoriatic Arthritis Therapeutics Drug Sales YoY (2019-2030) & (K Units)
    Figure 27. Asia (excluding China) Psoriatic Arthritis Therapeutics Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales YoY (2019-2030) & (K Units)
    Figure 29. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Psoriatic Arthritis Therapeutics Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Psoriatic Arthritis Therapeutics Drug in the World: Market Share by Psoriatic Arthritis Therapeutics Drug Revenue in 2023
    Figure 32. Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 34. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 35. Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 36. Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2019-2030)
    Figure 43. U.S. Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 46. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 48. Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2019-2030)
    Figure 50. Europe Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2019-2030)
    Figure 51. Germany Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 52. France Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 56. China Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 57. China Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 58. China Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 59. China Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 61. Asia Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 63. Asia Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Psoriatic Arthritis Therapeutics Drug Revenue Share by Region (2019-2030)
    Figure 65. Asia Psoriatic Arthritis Therapeutics Drug Sales Share by Region (2019-2030)
    Figure 66. Japan Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 70. India Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Psoriatic Arthritis Therapeutics Drug Sales Share by Country (2019-2030)
    Figure 77. Brazil Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Psoriatic Arthritis Therapeutics Drug Revenue (2019-2030) & (US$ Million)
    Figure 82. Psoriatic Arthritis Therapeutics Drug Value Chain
    Figure 83. Psoriatic Arthritis Therapeutics Drug Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Therapeutics Market Insights Forecast to 2030
Global Psoriasis Treatment Drugs Market Research Report 2025
Global Psoriasis Biologics Drugs Market Research Report 2025
Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Disease Modifying Antirheumatic Drug Market Insights Forecast to 2030
Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2024
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Arthritis Medications Market Research Report 2024
Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Joint Disease Therapeutics Market Research Report 2024
Global NSAIDs Market Research Report 2025
Global Rheumatoid Arthritis RA Medications Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions